Recorded Events

Post Fall Conference 2021 Webinar

Post Fall Conference 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts

Post Fall Conference 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts
Post-IAS 2021 Webinar

Post-IAS 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts

Post-IAS 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts
The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice

The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice

Paula Teichner, PharmD, AAHIVP, Regional Medical Lead

The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice

Paula Teichner, PharmD, AAHIVP, Regional Medical Lead
Post-CROI 2021 Webinar

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs
STAT 24 Week: Feasibility, Efficacy and Safety

STAT 24 Week: Feasibility, Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

STAT 24 Week: Feasibility, Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
TANGO 96 Week: Efficacy and Safety

TANGO 96 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

TANGO 96 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
GEMINI 144 Week: Efficacy and Safety

GEMINI 144 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

GEMINI 144 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
GEMINI 48 Week: Adherence Analysis

GEMINI 48 Week: Adherence Analysis

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

GEMINI 48 Week: Adherence Analysis

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir